{"id":"W4393085675","doi":"10.1158/1538-7445.am2024-1862","title":"Abstract 1862: ZW191 - a FRα-targeting antibody drug conjugate with strong preclinical activity across multiple FRα-expressing indications","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Antibody-drug conjugate; Medicine; Drug; Conjugate; Antibody; Pharmacology; Cancer research; Immunology; Monoclonal antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001935895,0.0005208552,0.0001908235,0.000263223,0.000109325,0.0002171169,0.000236707,0.000301133,0.002592741],"category_scores_gemma":[0.0001195232,0.0001465552,0.000180191,0.0002081977,0.0001101819,0.0002689125,0.0001445237,0.0004066842,0.0007875474],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004417893,"about_ca_system_score_gemma":0.0003023841,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006161152,"about_ca_topic_score_gemma":0.0006441699,"domain_scores_codex":[0.9998883,0.00001508022,0.000007862216,0.00002025347,0.00004370613,0.00002475496],"domain_scores_gemma":[0.9999359,0.000005524726,0.00002381549,0.000004352255,0.00001698623,0.00001346828],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002395017,0.00009274173,0.000210201,0.00005296292,0.000008958597,0.00004249404,0.00001229596,0.0002481606,0.9940538,0.0001388511,0.0002626275,0.004637339],"study_design_scores_gemma":[0.00005651063,0.001218858,0.001042479,0.00000420785,0.00001816297,0.0002215217,0.000005402286,0.0007938742,0.9919555,0.00001474334,0.004665257,0.000003492725],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9814523,0.002595853,0.00768452,0.000190636,0.00005452142,0.0002340283,0.0008667238,0.0001869227,0.006734523],"genre_scores_gemma":[0.980706,0.001612949,0.006459653,0.00007913857,0.00002331899,0.00007823658,0.001617614,0.00004587883,0.009377333],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002592741,"threshold_uncertainty_score":0.008673608,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1774213273968225,"score_gpt":0.5574039194081839,"score_spread":0.3799825920113614,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}